* Core Laboratories Inc CLB.N reported quarterly adjusted
earnings of 21 cents per share for the quarter ended in June.
The mean expectation of eight analysts for the quarter was
for earnings of 20 cents per share.
* Revenue rose 5.8% to $127.88 million from a year ago;
analysts
expected $131.46 million.
* Core Laboratories Inc's reported EPS for the quarter was
48
cents.
* The mean earnings estimate of analysts had fallen by
about 2.1%
in the last three months.
* In the last 30 days, four analysts negatively revised
earnings
estimates
* Core Laboratories Inc shares had risen by 5.3% this
quarter and
gained 20.8% so far this year.
* The company reported quarterly net income of $22.85
million.
* Wall Street's median 12-month price target for Core
Laboratories
Inc is $21.00
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 6
"hold" and 2 "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data July
26 at 11:34 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 0.20 0.21 Beat
Mar. 31 2023 0.16 0.19 Beat
Dec. 31 2022 0.20 0.20 Met
Sep. 30 2022 0.15 0.18 Beat